# the Effects of YangXinShi (YXS) on the Quality of Life and Exercise Tolerance in Patients With Chronic Heart Failure

> **NCT03333499** · PHASE1 · UNKNOWN · sponsor: **Dalian University** · enrollment: 80 (estimated)

## Conditions studied

- Chronic Heart Failure

## Interventions

- **DRUG:** YanXinShi placebo pills
- **DRUG:** YanXinShi pills
- **DRUG:** Trimetazidine pills
- **DRUG:** YanXinShi and Trimetazidine pills

## Key facts

- **NCT ID:** NCT03333499
- **Lead sponsor:** Dalian University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-01
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2017-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03333499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03333499, "the Effects of YangXinShi (YXS) on the Quality of Life and Exercise Tolerance in Patients With Chronic Heart Failure". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03333499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*